Event Details Investor Event Jun 3, 2021 at 8:00 AM EDT Investor event to present updated data from its Phase 2 skin cancer cohorts combining RP1 with Opdivo® and data from its Phase 1 study of RP2 alone and in combination with Opdivo. Click here for webcast Supporting Materials Replimune 2021 Virtual Investor Event Data Update Presentation 4 MB Print Page RSS Feeds RSS Feeds Email Alerts Email Alerts Contact IR Contact IR Search Search
Investor Event Jun 3, 2021 at 8:00 AM EDT Investor event to present updated data from its Phase 2 skin cancer cohorts combining RP1 with Opdivo® and data from its Phase 1 study of RP2 alone and in combination with Opdivo. Click here for webcast Supporting Materials Replimune 2021 Virtual Investor Event Data Update Presentation 4 MB
